TREATMENT WITH UPADACITINIB RESULTS IN THE INHIBITION OF A BROAD RANGE OF POTENTIALLY PATHOGENIC PATHWAYS IN NR-AXSPA AND BDMARD-IR AS PATIENTS: PROTEOMIC ANALYSIS FROM THE SELECT-AXIS 2 PHASE 3 STUDIES-MedSci.cn

TREATMENT WITH UPADACITINIB RESULTS IN THE INHIBITION OF A BROAD RANGE OF POTENTIALLY PATHOGENIC PATHWAYS IN NR-AXSPA AND BDMARD-IR AS PATIENTS: PROTEOMIC ANALYSIS FROM THE SELECT-AXIS 2 PHASE 3 STUDIES

Sornasse, T; Song, IH; Wung, P; Bi, Y; Ravishankar, B; Hu, HA; Maksymowych, WP

ANNALS OF THE RHEUMATIC DISEASES, 2023; 82 (): 879

科室
- - 订阅+
  - 更多科室
工具
服务